Literature DB >> 11560877

Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data.

J C Kalvass1, D A Tess, C Giragossian, M C Linhares, T S Maurer.   

Abstract

The influence of microsomal concentration on unbound fraction (fu(mic)), half-life (t(1/2)), apparent intrinsic clearance (CL(int,app)) and apparent Michaelis-Menten constant (K(m,app)) was examined for two compounds, one representative of high nonspecific binding to microsomes (compound A) and one representative of low (compound B). Kinetic parameters were estimated for the two probe compounds at two human microsomal protein concentrations (0.46 and 2.3 mg/ml) and cytochrome P450 concentrations (0.20 and 1.0 microM), representing a 5-fold difference in microsomal concentration. For compound A, fu(mic) and CL(int,app) were inversely proportional to microsomal concentration. Conversely, the K(m,app) of compound A was proportional to microsomal concentration and the half-life was unchanged. For compound B, half-life was inversely proportional to microsomal concentration. In this case, fu(mic), CL(int,app), and K(m,app) were not proportionally influenced. The experimental observations were entirely consistent with that predicted by a mathematical relationship between microsomal concentration, fu(mic), t(1/2), CL(int,app), and K(m,app). These results demonstrate that when nonspecific binding is extensive, CL(int,app) is dependent on the arbitrary choice of microsomal concentration included in the incubation.

Entities:  

Mesh:

Year:  2001        PMID: 11560877

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations.

Authors:  Michael A Mohutsky; Jenny Y Chien; Barbara J Ring; Steven A Wrighton
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

2.  Impact of Lipid Partitioning on the Design, Analysis, and Interpretation of Microsomal Time-Dependent Inactivation.

Authors:  Jaydeep Yadav; Ken Korzekwa; Swati Nagar
Journal:  Drug Metab Dispos       Date:  2019-05-01       Impact factor: 3.922

Review 3.  Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions.

Authors:  Jaydeep Yadav; Erickson Paragas; Ken Korzekwa; Swati Nagar
Journal:  Pharmacol Ther       Date:  2019-12-11       Impact factor: 12.310

4.  Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.

Authors:  Advait Nagle; Tao Wu; Kelli Kuhen; Kerstin Gagaring; Rachel Borboa; Caroline Francek; Zhong Chen; David Plouffe; Xuena Lin; Christopher Caldwell; Jared Ek; Suzanne Skolnik; Fenghua Liu; Jianling Wang; Jonathan Chang; Chun Li; Bo Liu; Thomas Hollenbeck; Tove Tuntland; John Isbell; Tiffany Chuan; Philip B Alper; Christoph Fischli; Reto Brun; Suresh B Lakshminarayana; Matthias Rottmann; Thierry T Diagana; Elizabeth A Winzeler; Richard Glynne; David C Tully; Arnab K Chatterjee
Journal:  J Med Chem       Date:  2012-04-23       Impact factor: 7.446

5.  Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam.

Authors:  Sara K Quinney; Shawn Knopp; Chien Chang; Stephen D Hall; Lang Li
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-09-11

6.  Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations.

Authors:  Meiling Ye; Ling Tang; Mengjun Luo; Jing Zhou; Bin Guo; Yangyuan Liu; Bo Chen
Journal:  Nanoscale Res Lett       Date:  2014-11-28       Impact factor: 4.703

7.  Anti-Trypanosomal Proteasome Inhibitors Cure Hemolymphatic and Meningoencephalic Murine Infection Models of African Trypanosomiasis.

Authors:  Srinivasa P S Rao; Suresh B Lakshminarayana; Jan Jiricek; Marcel Kaiser; Ryan Ritchie; Elmarie Myburgh; Frantisek Supek; Tove Tuntland; Advait Nagle; Valentina Molteni; Pascal Mäser; Jeremy C Mottram; Michael P Barrett; Thierry T Diagana
Journal:  Trop Med Infect Dis       Date:  2020-02-17

8.  Imidazolopiperazines: hit to lead optimization of new antimalarial agents.

Authors:  Tao Wu; Advait Nagle; Kelli Kuhen; Kerstin Gagaring; Rachel Borboa; Caroline Francek; Zhong Chen; David Plouffe; Anne Goh; Suresh B Lakshminarayana; Jeanette Wu; Hui Qing Ang; Peiting Zeng; Min Low Kang; William Tan; Maria Tan; Nicole Ye; Xuena Lin; Christopher Caldwell; Jared Ek; Suzanne Skolnik; Fenghua Liu; Jianling Wang; Jonathan Chang; Chun Li; Thomas Hollenbeck; Tove Tuntland; John Isbell; Christoph Fischli; Reto Brun; Matthias Rottmann; Veronique Dartois; Thomas Keller; Thierry Diagana; Elizabeth Winzeler; Richard Glynne; David C Tully; Arnab K Chatterjee
Journal:  J Med Chem       Date:  2011-06-23       Impact factor: 7.446

9.  Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors.

Authors:  Manuel Saldivia; Eric Fang; Xiaolei Ma; Elmarie Myburgh; Juliana B T Carnielli; Christopher Bower-Lepts; Elaine Brown; Ryan Ritchie; Suresh B Lakshminarayana; Yen-Liang Chen; Debjani Patra; Elizabeth Ornelas; Hazel X Y Koh; Sarah L Williams; Frantisek Supek; Daniel Paape; Richard McCulloch; Marcel Kaiser; Michael P Barrett; Jan Jiricek; Thierry T Diagana; Jeremy C Mottram; Srinivasa P S Rao
Journal:  Nat Microbiol       Date:  2020-07-13       Impact factor: 17.745

10.  Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.

Authors:  Shilpi Khare; Advait S Nagle; Agnes Biggart; Yin H Lai; Fang Liang; Lauren C Davis; S Whitney Barnes; Casey J N Mathison; Elmarie Myburgh; Mu-Yun Gao; J Robert Gillespie; Xianzhong Liu; Jocelyn L Tan; Monique Stinson; Ianne C Rivera; Jaime Ballard; Vince Yeh; Todd Groessl; Glenn Federe; Hazel X Y Koh; John D Venable; Badry Bursulaya; Michael Shapiro; Pranab K Mishra; Glen Spraggon; Ansgar Brock; Jeremy C Mottram; Frederick S Buckner; Srinivasa P S Rao; Ben G Wen; John R Walker; Tove Tuntland; Valentina Molteni; Richard J Glynne; Frantisek Supek
Journal:  Nature       Date:  2016-08-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.